Table 3 Means and standard error of the mean for outcome measures by time and group based on CVD risk factor sub-group (intent-to-treat analyses)
CHD risk factor | Time | Analysisa | |||
|---|---|---|---|---|---|
| Â | Baseline | 6-Months | 18-Months | Time x Group (F) | Effect sizeb |
Obese | Â | Â | Â | Â | Â |
Bodyweight | Â | Â | Â | 2.45 | .022 |
   Intervention (n= 133) | 97.86 (1.16) | 96.92 (1.17) | 97.71 (1.21) |  |  |
   Control (n= 93) | 95.56 (1.39) | 95.49 (1.40) | 96.67 (1.45) |  |  |
Obese | Â | Â | Â | Â | Â |
BMI≥30 kg.m-2 |  |  |  | 5.43* | .048 |
   Intervention (n= 133) | 35.37 (0.38) | 35.00 (0.39) | 35.04 (0.39) |  |  |
   Control (n= 93) | 34.68 (0.46) | 34.75 (0.48) | 35.22 (0.48) |  |  |
Hypertensive | Â | Â | Â | Â | Â |
SBP>150 mmHg | Â | Â | Â | 1.04 | .059 |
   Intervention (n= 31) | 150.49 (1.71) | 141.82 (2.16) | 138.23 (3.08) |  |  |
   Control (n= 18) | 153.71 (3.71) | 152.19 (4.68) | 144.74 (6.68) |  |  |
Hypertensive | Â | Â | Â | Â | Â |
DBP>90 mmHg | Â | Â | Â | 2.10 | .123 |
   Intervention ( n= 46) | 96.57 (0.97) | 90.72 (1.33) | 90.99 (1.30) |  |  |
   Control (n= 24) | 96.52 (1.58) | 94.44 (2.15) | 91.62 (2.11) |  |  |
Hypercholesterolemia | Â | Â | Â | Â | Â |
(≥5.2 mmol.l-1) |  |  |  | 3.01* | .036 |
   Intervention (n= 107) | 6.11 (0.07) | 5.90 (0.08) | 5.87 (0.08) |  |  |
   Control (n= 67) | 6.00 (0.08) | 5.92 (0.11) | 6.03 (0.11) |  |  |
Insufficiently | Â | Â | Â | Â | Â |
Active | Â | Â | Â | Â | Â |
<600 Met-mins .wk-1 | Â | Â | Â | 0.15 | .002 |
   Intervention ( n= 78) | 186.00 (22.50) | 1124.95 (198.13) | 2655.67 (372.16) |  |  |
   Control (n= 44) | 147.85 (30.59) | 1053.88 (269.44) | 2275.71 (506.09) |  |  |